Severe hypersensitivity secondary to extended carbamazepine administration
Rose, S.J.
Clinical Pharmacy 4(1): 19; 23
1985
ISSN/ISBN: 0278-2677 PMID: 3971680 Document Number: 256134
Document emailed within 1 workday
Related Documents
Hintsche-Kilger, B.B.; Fengler, J.D.; Baumgarten, R. 1990: Mononucleosis syndrome with hypersensitivity hepatitis following carbamazepine administration Zeitschrift für Arztliche Fortbildung 84(11): 551-553Báguena, F.; Sánchez, P.; Sánchez, C.; Garau, J. 1991: Glucocorticoids and severe carbamazepine toxicity Medicina Clinica 96(6): 237
Maragoto-Rizo, C.; Rodríguez-García, G.; Gómez-Fernández, L.; Suárez-Monteagudo, C.; Alessandrini-Gónzalez, R.; Ortega-Pérez, M. 2003: Prolonged syndrome of diarrhoea due to the administration of carbamazepine Revista de Neurologia 36(7): 699-700
Yang, H.-b.; Huang, D.-q.; Zhu, Y.-b. 2012: Carbamazepine caused severe drug eruption in treatment of tinnitus Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 47(3): 248-249
Crosley, C.J.; Swender, P.T. 1979: Dystonia associated with carbamazepine administration: experience in brain-damaged children Pediatrics 63(4): 612-615
Udawat, H.; Khandelwal, V.; D'Souza, P.; Goyal, R.K. 2001: Toxic epidermal necrolysis secondary to carbamazepine in a patient with human immunodeficiency virus infection Journal of the Association of Physicians of India 49: 918-919
Amore, B.M.; Kalhorn, T.F.; Skiles, G.L.; Hunter, A.P.; Bennett, G.D.; Finnell, R.H.; Nelson, S.D.; Slattery, J.T. 1997: Characterization of carbamazepine metabolism in a mouse model of carbamazepine teratogenicity Drug Metabolism and Disposition: the Biological Fate of Chemicals 25(8): 953-962
Dugué, J.; Céolin, R.; Rouland, J.C.; Lepage, F. 1991: Polymorphism of carbamazepine: solid-state studies on carbamazepine dihydrate Pharmaceutica Acta Helvetiae 66(11): 307-310
Hydzik, P.; Balicka-Slusarczyk, B.; Jastrzebski, M. 2011: Cardiologic interaction carbamazepine with atypical neuroleptics. Acute mixed carbamazepine and quetiapine intoxication--case report Przeglad Lekarski 68(8): 499-502
Bluth, M.H.; Beleza, P.; Hajee, F.; Jordão, M.J.é; Figueiredo, J.é; Almeida, F.; Smith-Norowitz, T. 2007: IgE-mediated hypersensitivity after ibuprofen administration Annals of Clinical and Laboratory Science 37(4): 362-365
Montoya-Cabrera, M.A.; Sauceda-García, J.M.; Escalante-Galindo, P.; Flores-Alvarez, E.; Ruiz-Gómez, A. 1996: Carbamazepine poisoning in adolescent suicide attempters. Effectiveness of multiple-dose activated charcoal in enhancing carbamazepine elimination Archives of Medical Research 27(4): 485-489
Sotolongo, R.P.; Neefe, L.I.; Rudzki, C.; Ishak, K.G. 1978: Hypersensitivity reaction to sulfasalazine with severe hepatotoxicity Gastroenterology 75(1): 95-99
Bridge, T.P.; Heseltine, P.N.; Parker, E.S.; Eaton, E.M.; Ingraham, L.J.; McGrail, M.L.; Goodwin, F.K. 1991: Results of extended peptide T administration in AIDS and ARC patients Psychopharmacology Bulletin 27(3): 237-245
Albert, J.P.; Schirmer, A.; Hartmann, F. 1980: Extended ACTH rapid test for differentiation of primary and secondary adrenal insufficiency Medizinische Klinik 75(19): 693-696
Baron, T.H.; Richter, J.E.; Singh, S.; Tennyson, G.S.; Andres, J.M. 1993: Unusual presentation of mucosal hypersensitivity secondary to gastroesophageal reflux disease American Journal of Gastroenterology 88(2): 289-292
Korsholm, A.S.; Ebbehøj, E.; Richelsen, B.ør. 2014: Rare, severe hypersensitivity reaction to potassium iodide Ugeskrift for Laeger 176(28): V01140002
Lee, H.Y.; Ariyasinghe, J.T.; Thirumoorthy, T. 2008: Allopurinol hypersensitivity syndrome: a preventable severe cutaneous adverse reaction? Singapore Medical Journal 49(5): 384-387
Dukes, C.S.; Sugarman, J.; Cegielski, J.P.; Lallinger, G.J.; Mwakyusa, D.H. 1992: Severe cutaneous hypersensitivity reactions during treatment of tuberculosis in patients with HIV infection in Tanzania Tropical and Geographical Medicine 44(4): 308-311
Gottlieb, A.B.; Gordon, K.B.; Lebwohl, M.G.; Caro, I.; Walicke, P.A.; Li, N.; Leonardi, C.L. 2004: Extended efalizumab therapy sustains efficacy without increasing toxicity in patients with moderate to severe chronic plaque psoriasis Journal of Drugs in Dermatology: Jdd 3(6): 614-624
Kennelly, C.; Barnes, S. 1998: Inadvertent i.v. administration of enteral formula causes adverse sequelae ranging from microembolism and hypersensitivity reactions to increased production of stool American Journal of Critical Care: An Official Publication American Association of Critical-Care Nurses 7(1): 80